Open Menu Close Menu Open Search Close Search Open Directory Close Directory

autologous bone marrow

Treatment of canine atopic dermatitis with intravenously administered autologous bone marrow

Monday, February 9th, 2015

Atopic dermatitis (AD) also known as atopic eczema, affects approximately 10% of dogs worldwide and is likely the most prevalent canine skin diseases requiring medical intervention. Current treatment options for dogs afflicted with this condition include antihistamines, corticosteroids, cyclosporine A, oclacitinib, and allergen-specific immunotherapy (ASIT) administered subcutaneously or sublingually, as well as adjunctive treatments such as topical and systemic antimicrobial therapy